Recap: Nektar Therapeutics Q3 Earnings

Nektar Therapeutics NKTR reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:22 PM.

Here's what investors need to know about the announcement.

Earnings

Nektar Therapeutics beat estimated earnings by 5.0%, reporting an EPS of $-0.19 versus an estimate of $-0.2.

Revenue was up $519 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 8.94% drop in the share price the next day.

Here's a look at Nektar Therapeutics's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -0.28 -0.25 -0.45 -0.45
EPS Actual -0.27 -0.25 -0.32 -0.31
Revenue Estimate 21.83M 19.84M 22.13M 22.61M
Revenue Actual 20.50M 21.59M 22.02M 23.62M

To track all earnings releases for Nektar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!